Quantitative Radiology Solutions (QRS) has entered into the next phase of the clinical evaluation of its Automatic Anatomy Recognition (AAR) software – start of clinical acceptability and efficiency evaluation.  Four academic medical centers have enrolled 214 studies into the evaluation whose endpoints will verify the accuracy, efficiency, and clinical acceptability of the AAR-generated contours for… Read More


  Quantitative Radiology Solutions (QRS) was awarded a second STTR grant from the National Cancer Institute (NCI) for development of software for automated PET/CT interpretation and reporting. This grant will allow the company to extend the application of  its Automatic Anatomy Recognition (AAR) software to automated disease burden estimation and standardized reporting on PET/CT images.… Read More


Quantitative Radiology Solutions (QRS) has raised an additional $230,000 from Phase 1 Ventures to support 510(k) clearance of its Automatic Anatomy Recognition (AAR) software for radiation treatment planning.  The company is leveraging an STTR grant from the National Cancer Institute to complete its product development and conduct a clinical evaluation at 4 academic medical centers. … Read More


QRS is proud to annouce Steve Owens has joined our team as Chief Technology Officer. Mr. Owens is an experienced leader of Innovation Centers focused on research, product development, software engineering, and IT operations in the pharmaceutical research and medical device industries. He has a record of accomplishment of leading and developing people and organizations transform… Read More


ASTRO 2017

QRS presented STTR Phase I results in 2 posters at ASTRO 2017: “Auto-contouring for Radiation Therapy: Challenges in Standardizing Object Definitions, Ground Truth Delineations, Object Quality and Image Quality” and  “A High-Performance Software System for Auto Contouring Anatomy in Adaptive Radiation Therapy.” ASTRO is the premier radiation oncology society in the world, with more than… Read More


QRS CEO Joe Camaratta presented at Life Sciences Future. Life Sciences Future is a conference bringing together Pennsylvania’s diverse life sciences industry – pharma, biotech, medical device and diagnostics, healthcare IT, contract research organizations, academic research institutions, and the investment community. Learn More… Read More


QRS CEO Joe Camaratta presented the company’s fund-raising opportunity at Mid-Atlantic Diamond Ventures Fall Forum. Mid-Atlantic Diamond Ventures (MADV) is an independent organization that assists emerging, technology-based companies in their effort to build sustainable businesses by better positioning their firms for funding while increasing value at an early and crucial stage. To date, 386 Mid-Atlantic companies have… Read More